ML18201A119

From kanterella
Jump to navigation Jump to search
608563 Amendment No. 15 for St. Luke'S Des Peres Episcopal-Presbyterian Hospital to License No. 24-32195-01
ML18201A119
Person / Time
Site: 03035144
Issue date: 07/19/2018
From: Dalzell J L
NRC/RGN-III
To:
St. Luke's Des Peres Hospital
References
608563
Download: ML18201A119 (3)


Text

NRC FORM 374 U.S. NUCLEAR REGULATORY COMMISSION MATERIALS LICENSE PAGE 1 OF 3 PAGES Amendment No. 15 Pursuant to the Atomic Energy Act of 1954, as amended, the Energy Reorganization Act of 1974 (Public Law 93-438), and Title 10, Code of Federal Regulations, Chapter I, Parts 30, 31, 32, 33, 34, 35, 36, 37, 39, 40, 70 and 71, and in reliance on statements and representations heretofore made by the licensee, a license is hereby issued authorizing the licensee to receive, acquire, possess, and transfer byproduct, source, and special nuclear material designated below; to use such material for the purpose(s) and at the place(s) designated below; to deliver or transfer such material to persons authorized to receive it in accordance with the regulations of the applicable Part(s). This license shall be deemed to contain the conditions specified in Section 183 of the Atomic Energy Act of 1954, as amended, and is subject to all applicable rules, regulations, and orders of the Nuclear Regulatory Commission now or hereafter in effect and to any conditions specified below. Licensee 1. St. Luke's Des Peres Episcopal-Presbyterian Hospital 2. 2345 Dougherty Ferry Road St. Louis, MO 63122 6. Byproduct, source, 7. and/or special nuclear material A. Any byproduct material A. permitted by 10 CFR 35.100 B. Any byproduct material B. permitted by 10 CFR 35.200 C. Any byproduct material C. permitted by 10 CFR 35.300 Chemical ~r physical Any Any Any In accordance with letter dated 4. Expiration Date: January 31, 2020 April 1-------------11---,,1111---1

5. Docket No.: 030-35144 Reference No.: Max.lm-i:>unt that licel;isee
9. Authorized use A. For use in uptake, dilution and excretion studies permitted by 10 CFR 35.100. B. For use in imaging and localization studies permitted by 10 CFR 35.200. C. 500 millicurie~tal C. For any use permitted by 10 CFR ,,_.. . , 41:\;f\ 35.300 . CONDITIONS
10. Licensed material may be used or stored at the licensee's facilities located at: 2345 Dougherty Ferry Road, St. Louis, Missouri, 63122 11. The Radiation Safety Officer (RSO) for this license is Gregory Cizek, M.D.

NRC FORM 374A U.S. NUCLEAR REGULATORY COMMISSION PAGE 2 OF 3 PAGES 12. MATERIALS LICENSE SUPPLEMENTARY SHEET License Number 24-32195-01 Amendment No. 15 B. The following individuals are authorize Authorized User{M.D.,D.0.,etc.)

Daniel Abodeely, M.D. Gregory Cizek, M.D. Karen F. Goodhope, M.D. Edward J. O'Brien, M.D. Matthew Scott Ruyle, M.D. Thomas M. Schroyer, M.D. David Wei-Han Wu, M.D. 10 CF~ 3~0, 1 CFR V"'l, Docket or Reference Number 030-35144 ) oral administration of sodium iodide-131 in e oral administration of sodium iodide-131 in the oral administration of sodium iodide-131 in NRC FORM 374A U.S. NUCLEAR REGULATORY COMMISSION PAGE 3 OF 3 PAGES MATERIALS LICENSE SUPPLEMENTARY SHEET License Number 24-32195-01 Amendment No. 15 Docket or Reference Number 030-35144

13. Except as specifically provided otherwise in this license, the licen~e~hall conduct its program in accordance with the statements, representations, and procedures contained in the doc'f!l'l!llf'rictJitiltCJQY/9Jlllosures, list_ed below. This license condition applies only to those procedures that are required to be submitt~~~er<!brdance with the ~tflcJlitns.

Additionally, this license condition does not limit the licensee's ability to make changes to the radia~"'rotection program as provided'ft~n 10 CFR 35.26. The U.S. Nuclear Regulatory Commission's regulations shall govern unle~ statements, representations, and p~dures in the licensee's application and correspondence are more restrictive than tf1'i:regulations.

A. Application dated July 29, 2009 (ML9Gol70 B. Letter dated March 18, 2011 (ML 11~58) C. Letter dated June 14, 2011 (ML 111 D. Letter dated April 11, 2018 (ML 181 FOR THE U.S. NUCLEAR REGULATORY COMMISSION Date: July 19, 2018 By:~D~ Region 3